Introducing Fitzpatrick’s www.BiologicsHQ.com BiologicsHQ is a new interactive web database that provides metrics and comprehensive analysis of aBLA activity, USPTO post grant proceedings and patent litigation for CDER-listed / 505(b)(2) biologic drugs. BIOLOGICS ® BiologicsHQ Search Free and predictive text search of the BiologicsHQ database BiologicsHQ Statistics Up-to-date metrics on biologics related USPTO post grant proceedings and patent litigations Search by biologic drug brand, scientific or company name
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Introducing Fitzpatrick’s
www.BiologicsHQ.comBiologicsHQ is a new interactive web database that provides metrics and comprehensive analysis of aBLA activity, USPTO post grant proceedings
and patent litigation for CDER-listed / 505(b)(2) biologic drugs.
BIOLOGICS®
BiologicsHQ Search
Free and predictive text search of the
BiologicsHQ database
BiologicsHQ Statistics
Up-to-date metrics on biologics related USPTO post grant proceedings and patent litigations
Search by biologic drug brand, scientific or
company name
For More Information On: www.BiologicsHQ.com April M. Breyer (212) 218-2561Corinne E. Atton (212) 218-2212
Fitzpatrick’s Biotechnology/ Biologics Group:Robert S. Schwartz, Ph.D. (212) 218-2298Brendan M. O’Malley, Ph.D. (212) 218-2249
Business Development & Marketing:Linda Ficano (212) 218-2284
Click to view information concerning
IPRs
Click to view “Spotlight On”
report for this drug
Click to view information concerning
patent litigations
BiologicsHQ Company Pagesprovide information about
biologic drug licensors
BiologicsHQ Product Pages provide information for CDER-listed /
505(2)(b) biologic drugs
Related Documents
